Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03503513 · ClinicalTrials.gov registry record · Phase 2
Gentamicin Bladder Instillations to Prevent Urinary Tract Infections in Patients With Spinal Cord Injury
A Phase 2 study, sponsored by University of Michigan.
- Completed
- Registry status
- Phase 2
- Development phase
- 23
- Enrollment target
NCT03503513 is a Phase 2 study that has completed, run by University of Michigan. The registered enrollment target is 23 participants.
The verdict
NCT03503513, a Phase 2 study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 23 participants
- Enrollment target
Study Summary
A non-randomized study evaluating the efficacy of intravesical gentamicin on the occurrence rate of urinary tract infections and bladder complications in patients after spinal cord injury (SCI), and to assess its effectiveness in promoting overall quality of life (QOL), community living, and participation.
Interventions
- DRUG Gentamicin Sulfate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2018-08-24 |
| Est. Completion | 2023-09-30 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03503513
The ClinicalTrials.gov registry entry for NCT03503513 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Gentamicin Sulfate is the first listed.
NCT03503513 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03503513 about?
NCT03503513 is a clinical study titled "Gentamicin Bladder Instillations to Prevent Urinary Tract Infections in Patients With Spinal Cord Injury". A non-randomized study evaluating the efficacy of intravesical gentamicin on the occurrence rate of urinary tract infections and bladder complications in patients after spinal cord injury (SCI), and to assess its effectiveness in promoting overall quality of life (QOL), community living, and partici...
What is the current status of trial NCT03503513?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 23 participants. The study started on 2018-08-24. Estimated completion is 2023-09-30.
What interventions are being tested in trial NCT03503513?
The interventions under investigation include: Gentamicin Sulfate (DRUG).
Who is sponsoring clinical trial NCT03503513?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.